Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease

NCT01590888 is registered in ClinicalTrials.gov with Prana Biotechnology Limited as lead sponsor.

NCT NCT01590888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease
Lead sponsor
Prana Biotechnology Limited
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
February 28, 2014
Enrollment
109 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease